Skip to main content

Advertisement

Log in

The Recommendation and Use of Extracorporeal Membrane Oxygenation (ECMO) in Cases Reported to the California Poison Control System

  • Original Article
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Introduction

Antidotes are available to treat some specific poisonings; however, the mainstay of treatment for the poisoned patient remains supportive care. Extracorporeal membrane oxygenation (ECMO) is one of the most aggressive supportive measures available to manage poisoned patients.

Objective

To characterize the recommendation and use of ECMO in cases reported to the California Poison Control System (CPCS).

Methods

This retrospective chart review queried the CPCS database from 1997 to 2016 for cases containing the American Association of Poison Control Centers (AAPCC) code for ECMO, and “ECMO” and “ECLS” free-text searches. The collected data included year, age, gender, substances involved, route of exposure, clinical effects, treatments, and medical outcome.

Results

A total of 94 cases discussed ECMO as a supportive option with 16 cases utilizing ECMO. Cases where ECMO was discussed rose from one case in 1997 to 13 cases in 2016. Of the 94 cases where ECMO was discussed, 38 cases (40%) involved toxicity from a cardiovascular agent(s) and 33 cases (35%) involved exposure to hydrocarbons. Of the 16 cases where ECMO was performed, 13 (81%) involved males. The median age was 17 years (range 1 month–54 years). Ten cases (63%) involve patients under the age of 18. In this series, 13 of 16 ECMO-supported patients survived (81%).

Conclusions

ECMO is being recommended more often for treatment of acute poisoning cases by the CPCS. All caregivers involved in the treatment of poisoning should gain a working knowledge of the potentially lifesaving technology of ECMO, its indications for use, adverse effects, and drug or poison interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S. Extracorporeal membrane oxygenation (ECMO) for severe toxicological exposures: review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2016;12:95–9.

    Article  CAS  PubMed  Google Scholar 

  2. Kerns WP, Heffner AC. Extracorporeal membrane oxygenation and cardiopulmonary bypass in the poisoned patient. In: Brent J, et al., editors. Critical Care Toxicology. Berlin: Springer; 2017.

    Google Scholar 

  3. DeLange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol. 2013;51(5):385–93.

    Article  CAS  Google Scholar 

  4. Extracorporeal Life Support Organization Center Directory. https://www.elso.org/Membership/CenterDirectory.aspx. Accessed 9 Jan 2019.

  5. California Poison Control System Activity Report 2018. (Internal document).

  6. Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J. 2004 annual report of the American Association of Poison Control Centers’ Toxic Exposure Surveillance System. Am J Emerg Med. 2005;23(5):589–666.

    Article  PubMed  Google Scholar 

  7. National poison data system coding user manual updated 8/10/2017. https://aapcc.org/data-system. Accessed 9 Jan 2019.

  8. Raghavendran K, Nemzek J, Napolitano LM, Knight PR. Aspiration-induced lung injury. Crit Care Med. 2011;39(4):818–26.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Swierzy M, Helmig M, Ismail M, Ruckert J, Walles T, Neudecker J. Pneumothorax. Zentralbl Chir. 2014;139(Suppl 1):S69–86.

    PubMed  Google Scholar 

  10. Arens AM, Anaebere TC, Horng H, Olson K. Fatal Taxus baccata ingestion with perimortem serum taxine B quantification. Clin Toxicol. 2016;54(9):878–80.

    Article  Google Scholar 

  11. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th annual report. Clin Toxicol. 2017;55(10):1072–254.

    Article  Google Scholar 

  12. Raleigh L, Ha R, Hill C. Extracorporeal membrane oxygenation applications in cardiac critical care. Semin Cardiothorac Vasc Anesth. 2015;19(4):342–52.

    Article  PubMed  Google Scholar 

  13. Centers for Medicare and Medicaid Services. Hospital compare list. https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/hospitalqualityinits/hospitalcompare.html. Accessed 11 Feb 2019.

  14. Cole J, Olives T, Litell J, Scharber S, Touroutoutoudis M, Singh P, et al. Extracorporeal membrane oxygenation (ECMO) for refractory shock due to poisoning: experience and trends from a Regional Poison Center. Clin Toxicol. 2018;56(10):936–7.

    Google Scholar 

  15. Banner W. Risks of extracorporeal membrane oxygenation: is there a role for use in the management of the acutely poisoned patient? Clin Toxicol. 1996;34(4):365–71.

    CAS  Google Scholar 

  16. Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med. 2015;191(8):894–901.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hsu C, Lee W, Wei H, Sung S, Huang C, Shih C, et al. Extracorporeal membrane oxygenation use, expenditure, and outcomes in Taiwan from 2000 to 2010. J Epidemiol. 2015;25(4):321–31.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mohan B, Gupta V, Ralhan S, Gupta D, Puri S, Wander GS, et al. Role of extracorporeal membrane oxygenation in aluminum phosphide poisoning-induced reversible myocardial dysfunction: a novel therapeutic modality. J Emer Med. 2015;49(5):651–6.

    Article  Google Scholar 

  19. Johnson NJ, Gaieski DF, Allen SR, Perrone J, DeRoos F. A review of emergency cardiopulmonary bypass for severe poisoning by cardiotoxic drugs. J Med Toxicol. 2013;9:54–60.

    Article  CAS  PubMed  Google Scholar 

  20. Masson R, Colas V, Parienti JJ, Lehoux P, Massetti M, Charbonneau P, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012;83:1413–7.

    Article  PubMed  Google Scholar 

  21. Haas NA, Wegendt C, Schaffler R, Kirchner G, Welisch E, Kind K, et al. ECMO for cardiac rescue in a neonate with accidental amiodarone overdose. Clin Res Cardiol. 2008;97:878–81.

    Article  PubMed  Google Scholar 

  22. Baud FJ, Megarbane B, Deye N, Leprince P. Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity. Crit Care. 2007;11:207.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bouchard NC, Weinberg RL, Burkart KM, Bacchetta M, Dzierba A, Story D, et al. Prolonged resuscitation for massive amlodipine overdose with maximal vasopressors, intralipids, and veno arterial–extracorporeal membrane oxygenation (VA ECMO). NACCT 2010. Clin Toxicol. 2010;48:604–67.

    Article  Google Scholar 

  24. Hendren WG, Schieber RS, Garrettson LK. Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med. 1989;18:984–7.

    Article  CAS  PubMed  Google Scholar 

  25. Babatasi G, Massetti M, Verrier V, Lehoux P, Le Page O, Bruno PG, et al. Severe intoxiciation with cardiotoxic drugs: value of emergency percutaneous cardiocirculatory assistance. Arch Mal Coeur Vaiss. 2001;94:1386–92.

    CAS  PubMed  Google Scholar 

  26. Durward A, Geurguerian AM, Lefebvre M, Shemie SD. Massive diltiazem overdose treated with extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2003;4:372–6.

    Article  PubMed  Google Scholar 

  27. Holzer M, Sterz F, Schoerkhuber W, Behringer W, Domanovits H, Weinmar D, et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med. 1999;27:2818–23.

    Article  CAS  PubMed  Google Scholar 

  28. Maclaren G, Butt W, Cameron P, Preovolos A, McEgan R, Marasco S. Treatment of polypharmacy overdose with multimodality extracorporeal life support. Anaesth Intensive Care. 2005;33:120–3.

    Article  CAS  PubMed  Google Scholar 

  29. Auzinger GM, Scheinkestel CD. Successful extracorporeal life support in a case of severe flecainide intoxication. Crit Care Med. 2001;29:887–90.

    Article  CAS  PubMed  Google Scholar 

  30. Corkeron MA, van Heerden PV, Newman SM, Dusci L. Extracorporeal circulatory support in near-fatal flecainide overdose. Anaesth Intensive Care. 1999;27:405–8.

    Article  CAS  PubMed  Google Scholar 

  31. Yasui RK, Culclasure TF, Kaufman D, Freed CR. Flecainide overdose; is cardiopulmonary support the treatment? Ann Emerg Med. 1997;29:680–2.

    Article  CAS  PubMed  Google Scholar 

  32. De Rita F, Barozzi L, Franchi G, Faggian G, Mazzucco A, Luciani GB. Rescue extracorporeal life support for acute verapamil and propranolol toxicity in a neonate. Artif Organs. 2011;35:416–20.

    Article  PubMed  Google Scholar 

  33. Kolcz J, Pietrzyk J, Januszewska K, Procelewska M, Mroczek T, Malec E. Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med. 2007;22:381–5.

    Article  PubMed  Google Scholar 

  34. McVey FK, Corke CF. Extracorporeal circulation in the management of massive propranolol overdose. Anaesthesia. 1991;46:744–6.

    Article  CAS  PubMed  Google Scholar 

  35. Scalzo AJ, Weber TR, Jaeger RW, Conners RH, Thompson MW. Extracorporeal membrane oxygenation for hydrocarbon aspiration. Am J Dis Child. 1990;144:867–71.

    CAS  PubMed  Google Scholar 

  36. Chyka PA. Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. J Toxicol Clin Toxicol. 1996;34:357–63.

    Article  CAS  PubMed  Google Scholar 

  37. Moller JC, Vardag AM, Jonas S, Tegtmeyer FK. Poisoning with volatile hydrocarbons. 3 cases and a review. Monatsschr Kinderheilkd. 1992;140:113–6.

    CAS  PubMed  Google Scholar 

  38. Bille AB, Pederson KD, Hertel S. Extracorporeal membrane oxygenation of a child with severe chemical pneumonia. Ugeskr Laeger. 2011;173:3115–6.

    PubMed  Google Scholar 

  39. Weber TR, Tracy TF, Connors R, Kountzman B, Pennington DG. Prolonged extracorporeal support for non-neonatal respiratory failure. J Pediatr Surg. 1992;27:1100–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Justin Lewis.

Ethics declarations

Conflicts of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lewis, J., Zarate, M., Tran, S. et al. The Recommendation and Use of Extracorporeal Membrane Oxygenation (ECMO) in Cases Reported to the California Poison Control System. J. Med. Toxicol. 15, 169–177 (2019). https://doi.org/10.1007/s13181-019-00704-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-019-00704-3

Keywords

Navigation